NEW YORK, June 18 (GenomeWeb News) - The European Union will provide €10 million over the next four years to fund a Cell Migration and Inflammation project, or MAIN, which will be aimed at identifying and characterizing the molecular mechanisms behind chronic inflammation, the EU said Thursday.
The project, which is being coordinated by Ruggero Pardi of the San Raffaele Scientific Institute in Milan, plans to include 150 researchers and graduate students from five EU countries, as well as Israel, and Switzerland. It will also work closely with the US cell migration consortium, in sharing technology and information, and in developing a coordinated scientific agenda.
"We believe that the most effective strategy to overcome barriers to progress in chronic inflammation is to promote synergistic interaction of scientists from many disciplines to challenge the aforementioned processes using a reductionist approach," an official MAIN statement reads.
MAIN will focus on four developmental research programs: tool development, target identification, target validation, and drug development. It will also include three support facilities: imaging, proteomics, and microarrays; as well as a bioinformatics core facility, according to the EU. Each facility will be coordinated by two researchers.